AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CT PRIVATE EQUITY TRUST PLC

Major Shareholding Notification Jan 13, 2022

4783_rns_2022-01-13_e76d7376-2086-480e-b5d0-0460ca1212da.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2754Y

BMO Private Equity Trust PLC

13 January 2022

To: Stock Exchange For immediate release:
13 January 2022

This announcement is released by BMO Private Equity Trust PLC and qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

BMO Private Equity Trust PLC

LEI: 2138009FW98WZFCGRN66

Proposed Secondary Placing

BMO Private Equity Trust plc ("BPET" or the "Company") has been advised that a shareholder is proposing to sell in aggregate 2.8 million shares of the Company, representing approximately 3.8 per cent of the Company's issued share capital.

The Company's corporate broker, Singer Capital Markets, is working with the potential seller in respect of the sale. The current intention is to conclude the sale by no later than 21 January 2022.

Institutions and other professional investors should contact Singer Capital Markets to express an interest.

The Company is not a party to the above placing and will not receive any proceeds from any sale of shares.

For further information please contact

BMO Private Equity Trust PLC
Hamish Mair (Investment Manager) 0131 718 1000
Scott McEllen (Company Secretary) 0131 718 1000
[email protected]   / [email protected]
Singer Capital Markets
Alan Ray / Robert Peel (Investment Banking) 0207 496 3000
James Waterlow (Sales) 0207 496 3031

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEMZGMMRZKGZZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.